These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 30831055

  • 1. Delineating the interaction of combretastatin A-4 with αβ tubulin isotypes present in drug resistant human lung carcinoma using a molecular modeling approach.
    Kumbhar BV, Bhandare VV, Panda D, Kunwar A.
    J Biomol Struct Dyn; 2020 Feb; 38(2):426-438. PubMed ID: 30831055
    [Abstract] [Full Text] [Related]

  • 2. Interaction of microtubule depolymerizing agent indanocine with different human αβ tubulin isotypes.
    Kumbhar BV, Panda D, Kunwar A.
    PLoS One; 2018 Feb; 13(3):e0194934. PubMed ID: 29584771
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Exploring the Origin of Differential Binding Affinities of Human Tubulin Isotypes αβII, αβIII and αβIV for DAMA-Colchicine Using Homology Modelling, Molecular Docking and Molecular Dynamics Simulations.
    Kumbhar BV, Borogaon A, Panda D, Kunwar A.
    PLoS One; 2016 Feb; 11(5):e0156048. PubMed ID: 27227832
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differential binding affinity of tau repeat region R2 with neuronal-specific β-tubulin isotypes.
    Bhandare VV, Kumbhar BV, Kunwar A.
    Sci Rep; 2019 Jul 25; 9(1):10795. PubMed ID: 31346240
    [Abstract] [Full Text] [Related]

  • 10. Mobility and Core-Protein Binding Patterns of Disordered C-Terminal Tails in β-Tubulin Isotypes.
    Laurin Y, Eyer J, Robert CH, Prevost C, Sacquin-Mora S.
    Biochemistry; 2017 Mar 28; 56(12):1746-1756. PubMed ID: 28290671
    [Abstract] [Full Text] [Related]

  • 11. Binding modes of cabazitaxel with the different human β-tubulin isotypes: DFT and MD studies.
    Zhu L, Zhang C, Lü X, Song C, Wang C, Zhang M, Xie Y, Schaefer HF.
    J Mol Model; 2020 May 30; 26(6):162. PubMed ID: 32474655
    [Abstract] [Full Text] [Related]

  • 12. Molecular dynamics simulation and free energy landscape methods in probing L215H, L217R and L225M βI-tubulin mutations causing paclitaxel resistance in cancer cells.
    Tripathi S, Srivastava G, Sharma A.
    Biochem Biophys Res Commun; 2016 Aug 05; 476(4):273-279. PubMed ID: 27233604
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Molecular insight of isotypes specific β-tubulin interaction of tubulin heterodimer with noscapinoids.
    Santoshi S, Naik PK.
    J Comput Aided Mol Des; 2014 Jul 05; 28(7):751-63. PubMed ID: 24916062
    [Abstract] [Full Text] [Related]

  • 15. 2-(m-Azidobenzoyl)taxol binds differentially to distinct β-tubulin isotypes.
    Yang CH, Yap EH, Xiao H, Fiser A, Horwitz SB.
    Proc Natl Acad Sci U S A; 2016 Oct 04; 113(40):11294-11299. PubMed ID: 27651486
    [Abstract] [Full Text] [Related]

  • 16. Combretastatin A-4 resistance in H460 human lung carcinoma demonstrates distinctive alterations in beta-tubulin isotype expression.
    Wehbe H, Kearney CM, Pinney KG.
    Anticancer Res; 2005 Oct 04; 25(6B):3865-70. PubMed ID: 16309172
    [Abstract] [Full Text] [Related]

  • 17. BetaIII-tubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability.
    Kamath K, Wilson L, Cabral F, Jordan MA.
    J Biol Chem; 2005 Apr 01; 280(13):12902-7. PubMed ID: 15695826
    [Abstract] [Full Text] [Related]

  • 18. Energetics of vinca alkaloid interactions with tubulin isotypes: implications for drug efficacy and toxicity.
    Lobert S, Frankfurter A, Correia JJ.
    Cell Motil Cytoskeleton; 1998 Apr 01; 39(2):107-21. PubMed ID: 9484953
    [Abstract] [Full Text] [Related]

  • 19. Microtubule dynamics, mitotic arrest, and apoptosis: drug-induced differential effects of betaIII-tubulin.
    Gan PP, McCarroll JA, Po'uha ST, Kamath K, Jordan MA, Kavallaris M.
    Mol Cancer Ther; 2010 May 01; 9(5):1339-48. PubMed ID: 20442307
    [Abstract] [Full Text] [Related]

  • 20. Peloruside- and laulimalide-resistant human ovarian carcinoma cells have βI-tubulin mutations and altered expression of βII- and βIII-tubulin isotypes.
    Kanakkanthara A, Wilmes A, O'Brate A, Escuin D, Chan A, Gjyrezi A, Crawford J, Rawson P, Kivell B, Northcote PT, Hamel E, Giannakakou P, Miller JH.
    Mol Cancer Ther; 2011 Aug 01; 10(8):1419-29. PubMed ID: 21653684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.